The BDNF Val66Met polymorphism has opposite effects on memory circuits of multiple sclerosis patients and controls

PLoS One. 2013 Apr 11;8(4):e61063. doi: 10.1371/journal.pone.0061063. Print 2013.

Abstract

Episodic memory deficits are frequent symptoms in Multiple Sclerosis and have been associated with dysfunctions of the hippocampus, a key region for learning. However, it is unclear whether genetic factors that influence neural plasticity modulate episodic memory in MS. We thus studied how the Brain Derived Neurotrophic Factor Val(66)Met genotype, a common polymorphism influencing the hippocampal function in healthy controls, impacted on brain networks underlying episodic memory in patients with Multiple Sclerosis. Functional magnetic resonance imaging was used to assess how the Brain Derived Neurotrophic Factor Val(66)Met polymorphism modulated brain regional activity and functional connectivity in 26 cognitively unimpaired Multiple Sclerosis patients and 25 age- and education-matched healthy controls while performing an episodic memory task that included encoding and retrieving visual scenes. We found a highly significant group by genotype interaction in the left posterior hippocampus, bilateral parahippocampus, and left posterior cingulate cortex. In particular, Multiple Sclerosis patients homozygous for the Val(66) allele, relative to Met(66) carriers, showed greater brain responses during both encoding and retrieval while the opposite was true for healthy controls. Furthermore, a robust group by genotype by task interaction was detected for the functional connectivity between the left posterior hippocampus and the ipsilateral posterior cingulate cortex. Here, greater hippocampus-posterior cingulate cortex connectivity was observed in Multiple Sclerosis Met(66) carriers relative to Val(66) homozygous during retrieval (but not encoding) while, again, the reverse was true for healthy controls. The Val(66)Met polymorphism has opposite effects on hippocampal circuitry underlying episodic memory in Multiple Sclerosis patients and healthy controls. Enhancing the knowledge of how genetic factors influence cognitive functions may improve the clinical management of memory deficits in patients with Multiple Sclerosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Brain-Derived Neurotrophic Factor / genetics*
  • Case-Control Studies
  • DNA Primers / genetics
  • Female
  • Genotype
  • Gyrus Cinguli / physiology*
  • Hippocampus / physiology*
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Memory Disorders / etiology
  • Memory Disorders / genetics*
  • Multiple Sclerosis / complications*
  • Neuronal Plasticity / genetics
  • Neuropsychological Tests
  • Polymerase Chain Reaction
  • Polymorphism, Genetic / genetics*

Substances

  • Brain-Derived Neurotrophic Factor
  • DNA Primers
  • BDNF protein, human

Grants and funding

This research was founded by the Fondazione Italiana Sclerosi Multipla (FISM) (grant number #2003/R/24). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.